Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 777.40
+37.00 (5.00%)
Aug 1, 2025, 3:29 PM IST
Chimerix Market Cap
Orchid Pharma has a market cap or net worth of 39.43 billion as of August 1, 2025. Its market cap has decreased by -31.80% in one year.
Market Cap
39.43B
Enterprise Value
39.38B
Revenue
9.22B
Ranking
n/a
PE Ratio
39.56
Stock Price
$777.40
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 39.43B, an increase of 5,320.93%. That is a compound annual growth rate of 131.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 39.43B | -56.98% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | 4.98B | 584.72% |
| Nov 3, 2020 | 727.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,159.97B |
| Divi's Laboratories | 1,765.37B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,062.98B |
| Zydus Lifesciences | 975.85B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 636.20B |